Apricus will now Enter with Impotence Cures

Apricus is a pharmaceutical company offering quality medications and drugs. The company is now seeking European approvals for selling brand new erectile dysfunction cream, which is recently introduced in the markets. The newly introduced creams could serve a super alternative treatment to quality medications and generic sex pills. Men now-a-days rely on quality generic drugs like Viagra, Levitra and Cialis. However, consistent and frequent consumption of these medications would not serve healthier.

Erectile dysfunction creams prove the best solution, since, they are required to be applied externally the chances of side effects and reactions are lowered to a major extent. Bassam Damaj, the president and chief executive of Apricus, getting the approvals for this ointment was a big thing. The cream is called Vitaros. However, the cream is under examinations, to evaluate its effectiveness and safety for people using the drug. The cream is a combination of alprostadil which is already FDA approved in USA.  The ointment takes the time of around five minutes to make a move, once the molecules get absorbed in the skin it starts performing. Vitaros is already approved for selling in Canada the cream is expected to appear in markets by 2011 endings.

Now Several UK and European Pharmacies under the shelter of UK-Medix

According to Paul Thompson, the head of forward planning and strategy at UKmedix, the company is planning for further expansion plans by emerging various well working pharmacies form UK and Europe. The decision was taken by evaluating incredible growth in the last two quarters of year 2010, this has concluded by strengthening the network of pharmacies within UK. As per their emerging plans, millions of investments are expected in 2011 an 2012.

UKmedix has set certain targets to achieve in the coming years, with this expansion the company is trying to ease their struggles of attaining the targets with huge investments in business. According to the management, as far as financial terms are concerned, they are planning to buy about a multi million Euro pharmaceutical markets throughout UK and Europe. However, according to their expansion plans, the company is making a huge investment in their staff with an intention to double up the work force.

UKmedix is a renowned pharmacy and is popular for providing impotence treatments and drugs like Cialis has been contributing majorly in generating revenue. According to the authorities, customers serve their main priority.  Complete assurance will be provided to customers in case of offering similar services and products; in fact the facilities may also increase for the betterment of customers. However, this expansion and merging would not affect the commitments given to the consumers.